Amryt Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 74.97% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.8%	Athyrium Capital Management, LP	8,857,269	US$130.2m	0%	65.89%
9.9%	Highbridge Capital Management, LLC	6,333,552	US$93.1m	0%	2.71%
9.9%	Stonepine Capital Management LLC	6,333,239	US$93.1m	1.69%	36.77%
5.63%	Rubric Capital Management LP	3,600,000	US$52.9m	0%	2.19%
4.17%	MPM Asset Management, L.L.C.	2,668,843	US$39.2m	0%	17.54%
3.56%	EdgePoint Investment Group Inc.	2,277,964	US$33.5m	0%	0.19%
3.28%	Aquilo Capital Management, LLC	2,098,993	US$30.9m	5%	14.98%
3.13%	UBS O'Connor LLC	2,000,000	US$29.4m	0%	1.34%
2.66%	Handelsbanken Asset Management	1,699,975	US$25.0m	2.98%	0.05%
2.25%	Nantahala Capital Management, LLC	1,437,458	US$21.1m	0%	1.95%
2.13%	Chelverton Asset Management Limited	1,362,700	US$20.0m	0%	1.09%
2.07%	Rock Springs Capital Management LP	1,325,625	US$19.5m	0%	0.47%
2.05%	GLG Partners, Inc.	1,309,234	US$19.2m	0%	0.46%
2.03%	GLG Partners LP	1,300,062	US$19.1m	0%	0.29%
1.53%	Armistice Capital, LLC	978,000	US$14.4m	-23.1%	0.36%
1.1%	Joseph Wiley	704,616	US$10.4m	0.46%	no data
0.99%	Clearline Capital LP	631,942	US$9.3m	0%	1.48%
0.79%	Global Frontier Investments, LLC	505,000	US$7.4m	0%	1.92%
0.73%	Whitebox Advisors LLC	466,712	US$6.9m	0%	0.76%
0.7%	New Leaf Venture Partners, LLC	449,737	US$6.6m	0%	5.59%
0.61%	Raymond Stafford	392,720	US$5.8m	2.61%	no data
0.51%	Rory Nealon	328,904	US$4.8m	2.1%	no data
0.49%	Bruce & Co Inc	315,182	US$4.6m	0%	1.29%
0.48%	Samsara BioCapital LLC	304,715	US$4.5m	0%	0.97%
0.46%	Wells Fargo & Company, Securities and Brokerage Investments	293,398	US$4.3m	27.5%	no data